Journal: Neoplasia (New York, N.Y.)
Article Title: Cytoplasmic TRADD Confers a Worse Prognosis in Glioblastoma 1 2
doi:
Figure Lengend Snippet: (A) U251MG cells were infected with control (scrambled) lentivirus or with TRADD shRNA lentivirus, followed by puromycin selection and Western blot of clones infected with TRADD shRNA. Clones 15 and 26 show the best silencing of TRADD. (B) Degradation of IκBα in response to TNF-α (20 ng/ml) can be seen in U251MG control shRNA cells, showing that TNF-α activates NF-κB in these cells. (C and D) Failure of IκBα degradation in response to TNF-α in TRADD-silenced clones 15 and 26, demonstrating that TRADD is essential for NF-κB activation. (E) A reporter assay in clone 26 with an NF-κB responsive luciferase reporter. While NF-κB transcriptional activity increases in response to TNF-α in control shRNA cells, there is no increase in TRADD-silenced clone 26, again confirming the requirement for TRADD in NF-κB activation (one-way ANOVA, P = .0031). (F) Western blot showing that phosphorylation of the p65 subunit of NF-κB is in response to TNF-α is impaired in TRADD-silenced clone 26. (G) Quantitative real-time polymerase chain reaction experiment showing that mRNA levels of the NF-κB target gene IL-8 is decreased in TRADD-silenced clone 26, both at a basal level (P ≤ .0001) and in response to TNF-α (P ≤ .0001) compared to control. Newman-Keuls multiple comparison test was used for statistical analysis.
Article Snippet: RNA Interference TRADD was silenced using lentiviral shRNA ready-to-use transduction particles from Santa Cruz Biotechnology (sc-36709-V, containing three target-specific constructs) and puromycin selection according to the manufacturer's protocol.
Techniques: Infection, Control, shRNA, Selection, Western Blot, Clone Assay, Activation Assay, Reporter Assay, Luciferase, Activity Assay, Phospho-proteomics, Real-time Polymerase Chain Reaction, Comparison